CLINICAL ACTIVITY OF SEQUENTIAL FLAVOPIRIDOL, CYTOSINE ARABINOSIDE, AND MITOXANTRONE FOR ADULTS WITH NEWLY DIAGNOSED, POOR RISK ACUTE MYELOGENOUS LEUKEMIA

類似資料

• Phase 1 and pharmacokinetic study of bolus-infusion flavopiridol followed by cytosine arabinoside and mitoxantrone for acute leukemias
  著者:: Karp, Judith E., 等
  出版事項: (2011)
• Randomized phase II study of two schedules of flavopiridol given as timed sequential therapy with cytosine arabinoside and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemia
  著者:: Karp, Judith E., 等
  出版事項: (2012)
• The pharmacokinetics of subcutaneous cytosine arabinoside in patients with acute myelogenous leukaemia.
  著者:: Slevin, M L, 等
  出版事項: (1981)
• Phase I and Pharmacologic Trial of Cytosine Arabinoside with the Selective Checkpoint 1 Inhibitor Sch 900776 in Refractory Acute Leukemias
  著者:: Karp, Judith E., 等
  出版事項: (2012)
• Sensitivity of normal and acute myelogenous leukaemia marrow cells to inhibition by cytosine arabinoside.
  著者:: Potter, C. G., 等
  出版事項: (1980)